Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$14.47 - $18.17 $90,032 - $113,053
-6,222 Reduced 62.13%
3,792 $68,000
Q3 2022

Nov 07, 2022

BUY
$9.24 - $15.79 $92,529 - $158,121
10,014 New
10,014 $149,000
Q2 2022

Aug 09, 2022

SELL
$8.28 - $13.88 $33,120 - $55,520
-4,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.18 - $24.02 $21,242 - $45,638
1,900 Added 90.48%
4,000 $44,000
Q4 2021

Feb 11, 2022

BUY
$20.95 - $26.88 $43,995 - $56,448
2,100 New
2,100 $49,000
Q3 2021

Nov 09, 2021

SELL
$17.26 - $27.08 $6,904 - $10,832
-400 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$17.76 - $24.83 $7,104 - $9,932
400 New
400 $8,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.52B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.